(IN BRIEF) Roche presented new data at the AD/PD 2025 International Conference demonstrating that trontinemab, in its Phase Ib/IIa Brainshuttle™ AD study, achieves rapid and dose-dependent reductions of amyloid plaques in the brain, with significant biomarker improvements observed in fluid … Read the full press release
Posted in Austria, Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged AD/PD 2025 International Conference, Alzheimer’s disease, amyloid plaques, ARIA-E, biomarkers, Brainshuttle AD study, cognitive impairment, diagnostic solutions, dose-dependent reduction, Elecsys pTau181 plasma test, Levi Garraway, neurogranin, Phase Ib/IIa study, Phase III programme, pTau181, pTau217, Roche, total tau, trontinemab
(IN BRIEF) Effective 3 April 2025, Novo Nordisk will undergo key changes in its Executive Management. Camilla Sylvest, a long-time leader with 28 years at the company, has decided to step down. In response, Ludovic Helfgott will assume expanded responsibilities … Read the full press release
Posted in Business, Denmark, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged appointment, Camilla Sylvest departure, executive management, Executive Team, Global Communication, IT & Environmental Affairs, leadership, Leadership changes, Ludovic Helfgott, Novo Nordisk, organizational restructuring, Product & Portfolio Strategy, Quality, strategic leadership, Tania Sabroe, Thilde Hummel Bøgebjerg
(IN BRIEF) Rilzabrutinib, an investigational oral BTK inhibitor, has received orphan drug designation from the FDA for treating warm autoimmune hemolytic anemia (wAIHA) and IgG4-related disease (IgG4-RD), two rare conditions with no approved treatments. This designation, aimed at addressing unmet … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged BTK inhibitor, clinical trials, FDA, IgG4-RD, IgG4-related disease, immune thrombocytopenia, ITP, multi-immune modulation, orphan drug designation, phase 2a study, phase 2b study, rare diseases, regulatory review, rilzabrutinib, Sanofi, unmet medical need, wAIHA, warm autoimmune hemolytic anemia
(IN BRIEF) Boehringer Ingelheim, via its subsidiary NBE Therapeutics, has launched a cutting-edge ADC research and development facility in Basel with a CHF 27 million investment. The center is a key part of the company’s strategic efforts to advance next-generation … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged ADC, Basel, Boehringer Ingelheim, Cancer Therapies, CHF 27 million, DGNB Certificate Gold, Jean Engela, Karl Penz, Kaspar Sutter, NBE Therapeutics, oncology research, Swiss biotech, Synaffix B.V., Vienna
(IN BRIEF) A landmark international study has provided robust evidence that elevated levels of prolactin, a hormone involved in breast development, increase the risk of breast cancer in post-menopausal women. Researchers from The Institute of Cancer Research in London, along … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged B2Risk consortium, BMI, breast cancer, Breast Cancer Now, cohort studies, Dr Simon Vincent, early diagnosis, ICR, Institute of Cancer Research, invasive breast cancer, mammographic density, personalized prevention, plasma levels, PMH, polygenic risk score, post-menopausal, Professor Montse Garcia-Closas, prolactin, risk factor, targeted interventions
(IN BRIEF) A groundbreaking AI-powered research platform, POETIC-AI, has been unveiled by scientists from The Institute of Cancer Research, promising to accelerate cancer biomarker discovery. Demonstrated at The Alan Turing Institute’s fifth AI UK conference, the platform integrates diverse clinical … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged artificial intelligence, biomarkers, cancer research, Cancer Research UK, clinical trial data, Collaborative Research, CT, digital pathology, Dr. Ferran Cardo, Dr. Maggie Cheang, hormone therapy, ICR, Integrated Discovery and Diagnostics programme, Ki67, medical imaging, MRI, natural language AI, Palantir Foundry, POETIC trial, POETIC-AI, Professor Manuel Salto-Tellez, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Xixuan Zhu
(IN BRIEF) SYNLAB has sold its operations in Eastern Europe—specifically in Croatia, Cyprus, North Macedonia, Romania, Slovenia, and Turkey—to Medicover Group, a major European healthcare provider. This move, representing about 1.5% of SYNLAB’s 2024 revenue, is part of the company’s … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged capital deployment, CROATIA, Cyprus, diagnostic services, divestiture, Eastern Europe, Mathieu Floreani, Medicover Group, network densification, NORTH MACEDONIA, partnership, portfolio management, revenue 2024, Romania, Slovenia, specialty testing, strategic growth, Synlab, Turkey
(IN BRIEF) At CHINAPLAS 2025 in Shenzhen, BASF presented Össur’s Pro-Flex® Terra foot prosthesis, featuring BASF’s Cellasto® microcellular material that emulates the natural motion of human muscles and tendons. The prosthetic foot, with its innovative three-step foam design, adapts to … Read the full press release
Posted in Business, Chemicals, Financial, Germany, Government, Healthcare, Iceland, Industrial, Investment, Management, Marketing, Media, News, Technology
Tagged automated mold lines, BASF, Bjoern Kophstahl, Cellasto®, CHINAPLAS 2025, durability, energy return, extreme conditions, Felix Starker, flexibility, lifecycle testing, microcellular material, mobility, muscle-tendon motion, Össur, partnership, Pro-Flex® Terra, prosthetic foot, three-step foam design, user testing
(IN BRIEF) At in-cosmetics Global 2025 in Amsterdam, BASF launches its Longevity Ecosystem, an innovative approach in personal care focused on planetary, emotional, and physical well-being. The initiative, part of BASF’s Beyond Beauty journey, introduces sustainable alternatives like Verdessence® Maize … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, Media, Netherlands, News, Science, Technology
Tagged Amsterdam, BASF, Beyond Beauty, Dr. Bianca Seelig, Dr. Boris Gaspar, emotional well-being, ethical sourcing, FairWild, healthy aging, in-cosmetics Global 2025, Lamesoft OP Plus, Longevity Ecosystem, Marcel Schnyder, MindMotion technology, Oximony, personal care, physical well-being, planetary well-being, regulatory changes, sustainability, Sustainable Ingredients, Verdessence Maize
(IN BRIEF) Siemens AG and Siemens Healthineers AG have each donated €100,000 for immediate earthquake relief in Myanmar and Thailand, and have initiated an internal donation drive where every euro contributed by employees will be matched. This aid, distributed through … Read the full press release
Posted in Business, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Management, News, Non Profit, Technology
Tagged 000 donation, Disaster Response, earthquake relief, employee matching, FOOD, humanitarian assistance, internal donation drive, Judith Wiese, medical care, Myanmar, Peter Koerte, shelter, Siemens AG, Siemens Caring Hands e.V., Siemens Healthineers AG, THAILAND, WATER, €100
(IN BRIEF) Alcura France, a fully owned subsidiary of Mutares SE & Co. KGaA, has received a firm acquisition proposal for its home healthcare services division (PSAD) from Santé Cie Group, a key European provider of homecare and ambulatory services. … Read the full press release
Posted in Business, Financial, France, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged 2024 revenue, acquisition offer, Alcura France, ambulatory care, CIO, EUR 17 million, home healthcare services, homecare, Johannes Laumann, M&A, MA&D, maintien à domicile, Mutares SE & Co. KGaA, partnership, PSAD, Santé Cie Group, shareholder returns, works councils
(IN BRIEF) In 2023, a historic initiative saw all 27 EU countries, along with Iceland and Norway, collecting and reporting both sales and usage data on veterinary antimicrobials for the first time. The resulting ESUAvet report details that 98% of … Read the full press release
Posted in Business, European Union, Financial, Government, Healthcare, Iceland, Industrial, Investment, Management, Netherlands, News, Norway, Science, Technology
Tagged 2023, AMEG, Animal Health, antimicrobial resistance, antimicrobials, ASU Platform, breeders, Category B, Category C, Category D, Cattle, chickens, EMA, ESUAvet, ESVAC, EU27, European Union, farmers, feed mills, food-producing animals, Iceland, Norway, penicillins, pharmacies, pigs, public health, retailers, sales data, sulfonamides, tetracyclines, turkeys, usage data, veterinarians, veterinary medicine
(IN BRIEF) Researchers have developed an AI algorithm that predicts a heart’s “biological” age using standard 12-lead ECG data. Presented at EHRA 2025, the study found that a biological heart age that is seven years older than the actual age … Read the full press release
Posted in Artificial Intelligence (AI), Austria, Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Media, News, Science, Technology
Tagged 12-lead ECG, AI algorithm, Associate Professor Yong-Soo Baek, Cardiovascular risk, chronological age, deep learning, Early Detection, EHRA 2025, ejection fraction, electrical remodelling, European Society of Cardiology, heart biological age, MACE, major adverse cardiovascular events, mortality risk, neural network, preventive strategies, QRS duration, QT interval
(IN BRIEF) IO Biotech, a Danish med-tech company, has obtained €57.5 million in venture debt financing from the European Investment Bank, with backing from the European Commission’s InvestEU programme. The financing, structured in three committed tranches of up to €37.5 … Read the full press release
Posted in Banks, Denmark, European Union, Financial, Healthcare, Investment, Luxembourg, Pharma & Biotech, Technology
Tagged Amy Sullivan, cancer vaccine, clinical development, EIB, European Commission, immunotherapeutic, InvestEU, IO Biotech, IO102-IO103, Ioannis Tsakiris, market launch, med-tech, melanoma, oncology, Pharmaceutical, regulatory approval, T-Win® platform, venture debt
(IN BRIEF) The EU-funded DORIAN GRAY project, with the University of Liverpool as a key scientific partner, is set to explore the link between cardiovascular disease (CVD) and mild cognitive impairment (MCI). Despite one in three CVD patients experiencing MCI, … Read the full press release
Posted in Education, Healthcare, Science, Society, United Kingdom
Tagged AI, biomarkers, cardiovascular disease, clinical trial, cognitive training, CVD, dementia reduction, digital tool, DORIAN GRAY, Dr Riccardo Proietti, EU-funded, heart failure, Horizon Europe, international collaboration, Liverpool Clinical Trials Centre, MCI, medical avatar, mild cognitive impairment, Prevention Strategies, Professor Carrol Gamble, risk model, University of Brescia, University of Liverpool
(IN BRIEF) A new White Paper, developed by the Centre for Assuring Autonomy at the University of York, the MPS Foundation, and the Bradford Institute for Health Research, warns that the benefits of AI in patient care could be lost … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Healthcare, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, AI decision-support tools, AI Integration, Bradford Institute for Health Research, burnout, Centre for Assuring Autonomy, clinician autonomy, Clinicians, healthcare technology, Improvement Academy, liability sink, MPS Foundation, NHS, patient care, product liability, Professor Gozie Offiah, Professor Ibrahim Habli, Professor Tom Lawton, real-world scenarios, regulatory reform, Shared CAIRE, University of York, white paper
(IN BRIEF) Sanofi’s mRNA vaccine candidate for chlamydia has been granted fast track designation by the US FDA, reflecting its promising potential to address a significant public health issue. Designed to protect against primary and recurrent infections caused by Chlamydia … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged asymptomatic infection, chlamydia, Chlamydia trachomatis, Fast Track Designation, Griffith University, immunogenicity, infertility, Jean-François Toussaint, mRNA vaccine candidate, pelvic inflammatory disease, phase 1/2 clinical study, pregnancy complications, public health need, Queensland Government, safety, Sanofi, Translational Science Hub, University of Queensland, US Food and Drug Administration
(IN BRIEF) The EQT Foundation has opened a global call for proposals under its Breakthrough Science grants program, offering grants from €25,000 to €100,000 to researchers focused on addressing critical female health challenges with deeptech solutions. The initiative seeks to … Read the full press release
Posted in Business, Healthcare, Industrial, Investment, Pharma & Biotech, Sweden
Tagged 000, accredited institutions, Autoimmune Disorders, Breakthrough Science, cardiovascular diseases, commercialization, deeptech, diagnostics, endometriosis, EQT Foundation, female health challenges, financial support, global call for proposals, grants program, gynecological conditions, low-resource settings, maternal health, mentorship, Research & Innovation, therapeutics, Women’s Health
(IN BRIEF) The DataTools4Heart (DT4H) project, funded under the European Union’s Horizon Europe Framework, has successfully concluded its initial development phase and is set to achieve major milestones in 2025. Focused on enhancing the lifestyle of cardiovascular disease patients, DT4H … Read the full press release
Posted in Artificial Intelligence (AI), European Union, France, Healthcare, Industrial, Italy, Management, News, Pharma & Biotech, Science, Technology
Tagged AI-powered analytics, Barcelona Supercomputing Center, cardiology data reuse, cardiovascular disease, clinical data, clinician engagement, Cristian Izquierdo, data synthesis, DataTools4Heart, DT4H, eight hospitals, ESC Congress, European Union, federated learning, Horizon Europe, Laura G. Antiga, multilingual natural language processing, privacy-preserving, secure toolkit, Sophia Antipolis, stable software, unified interface, University of Barcelona
(IN BRIEF) Scientists at The Institute of Cancer Research in London have made significant strides in understanding why some cases of neuroblastoma—a pediatric cancer of nerve tissue—result in poorer outcomes. Their research indicates that mutations in the ATRX gene, which … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ATRX gene, Cancer Letters, Cancer Research UK, Dr Sally George, Federica Lorenzi, high-risk, immune cell infiltration, inflammatory pathways, macrophages, MYCN gene amplification, Neuroblastoma, Neuroblastoma UK, paediatric oncology, personalised therapy, targeted treatment, The Institute of Cancer Research, TIME, tumour immune microenvironment
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?